Suppr超能文献

血小板受体脱落的基本机制。

Basic mechanisms of platelet receptor shedding.

作者信息

Andrews Robert K, Gardiner Elizabeth E

机构信息

a Australian Centre for Blood Diseases , Monash University , Melbourne , Australia 3004.

b Department of Cancer Biology and Therapeutics, the John Curtin School of Medical Research , Australian National University , Canberra , Australia 2600.

出版信息

Platelets. 2017 Jun;28(4):319-324. doi: 10.1080/09537104.2016.1235690. Epub 2016 Oct 25.

Abstract

Proteolytic shedding of the extracellular ectodomain of platelet receptors provides a key mechanism for irreversible loss of ligand-binding capacity, and for regulating platelet function in health and disease. Platelets derived from megakaryocytes are small anucleate cells in peripheral blood, with the ability to rapidly adhere, become activated, and secrete an array of procoagulant and proinflammatory factors at sites of vascular injury or disease, and to form a platelet aggregate (thrombus) which is not only critical in normal hemostasis and wound healing, but in atherothrombotic diseases including myocardial infarction and ischemic stroke. Basic mechanisms of receptor shedding on platelets have important distinctions from how receptors on other cell types might be shed, in that shedding is rapidly initiated (within seconds to minutes) and occurs under altered shear conditions encountered in flowing blood or experimentally ex vivo. This review will consider the key components of platelet receptor shedding, that is, the receptor with relevant cleavage site, the (metallo)proteinase or sheddase and how its activity is regulated, and the range of known regulatory factors that control platelet receptor shedding including receptor-associated molecules such as calmodulin, factors controlling sheddase surface expression and activity, and other elements such as shear stress, plasma membrane properties, cellular activation status or age. Understanding these basic mechanisms of platelet receptor shedding is significant in terms of utilizing receptor surface expression or soluble proteolytic fragments as platelet-specific biomarkers and/or ultimately therapeutic targeting of these mechanisms to control platelet reactivity and function.

摘要

血小板受体细胞外结构域的蛋白水解切割是导致配体结合能力不可逆丧失的关键机制,也是在健康和疾病状态下调节血小板功能的关键机制。源自巨核细胞的血小板是外周血中的小无核细胞,能够在血管损伤或疾病部位迅速黏附、活化并分泌一系列促凝血和促炎因子,还能形成血小板聚集体(血栓),这不仅在正常止血和伤口愈合中至关重要,在包括心肌梗死和缺血性中风在内的动脉粥样硬化血栓形成疾病中也起着关键作用。血小板上受体切割的基本机制与其他细胞类型上受体的切割方式有重要区别,因为切割过程迅速启动(数秒至数分钟内),且发生在流动血液或实验离体条件下遇到的剪切力改变的情况下。本综述将探讨血小板受体切割的关键组成部分,即具有相关切割位点的受体、(金属)蛋白酶或切割酶及其活性如何被调节,以及控制血小板受体切割的已知调节因子的范围,包括受体相关分子如钙调蛋白、控制切割酶表面表达和活性的因子,以及其他因素如剪切应力、质膜特性、细胞活化状态或细胞年龄。了解血小板受体切割的这些基本机制对于将受体表面表达或可溶性蛋白水解片段用作血小板特异性生物标志物和/或最终针对这些机制进行治疗性靶向以控制血小板反应性和功能具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验